Saturday, June 03, 2017 4:32:47 PM
Patents are taken care of-wrong
The patent for CIAB with Cytochrome P450 producing cells to be used for cancer, specifying Cyclophosphamide or Ifosfamide as the prodrugs has expired. It's a patent dating back to Gunzberg.
PMCB claims they filed a new patent. Which would require something new over the original patent, and considered not obvious by the USPO. Care to provide a patent number for the claimed filing? And no, claiming it takes time to be posted by the USPO doesn't cut it. Once in, PMCB is free to disclose what makes the new patent unique vs the older one. Including the patent number assigned. So where's the details?
BTW - Gunzberg has been busy filing patents, for a cellulose based encapsulation vehicle, which can actually be found when searched for. One of latest is to provide acid protection of substances encapsulated while transversing the stomach into the intestines. Of course it has nothing to do with CIAB+ an alkylating prodrug for cancer.
The patent for CIAB with Cytochrome P450 producing cells to be used for cancer, specifying Cyclophosphamide or Ifosfamide as the prodrugs has expired. It's a patent dating back to Gunzberg.
PMCB claims they filed a new patent. Which would require something new over the original patent, and considered not obvious by the USPO. Care to provide a patent number for the claimed filing? And no, claiming it takes time to be posted by the USPO doesn't cut it. Once in, PMCB is free to disclose what makes the new patent unique vs the older one. Including the patent number assigned. So where's the details?
BTW - Gunzberg has been busy filing patents, for a cellulose based encapsulation vehicle, which can actually be found when searched for. One of latest is to provide acid protection of substances encapsulated while transversing the stomach into the intestines. Of course it has nothing to do with CIAB+ an alkylating prodrug for cancer.
The Jewel of the Mind is Colored with the Hue of what it Imagines
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
